Effect of an Anterior Chamber Infusion System on Trabeculectomy Outcomes
NCT ID: NCT00551902
Last Updated: 2015-09-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
PHASE1
INTERVENTIONAL
2007-09-30
2010-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective Randomized Study Comparing Ex-PRESS to Trabeculectomy
NCT01263561
Timing of Treatment Completion in Staged Selective Laser Trabeculoplasty (SLT): Early vs. Late Completion
NCT00551395
Primary Tube Versus Trabeculectomy Study
NCT00666237
Inflammatory Mediators of Glaucoma After Corneal Transplantation (AH-Tears)
NCT04339907
Optical Coherence Tomography of the Irido-Corneal Angle Before and After Goniotomy and Trabeculotomy in Primary Congenital Glaucoma
NCT07012252
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Thus, the hypothesis of this study is that the use of an anterior chamber infusion system improves success of trabeculectomy surgery.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Trabeculectomy with anterior chamber infusion system
Trabeculectomy with anterior chamber infusion system
Trabeculectomy with anterior chamber infusion system
2
Trabeculectomy without anterior chamber infusion system
Trabeculectomy without anterior chamber infusion system
Standard trabeculectomy surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Trabeculectomy with anterior chamber infusion system
Trabeculectomy with anterior chamber infusion system
Trabeculectomy without anterior chamber infusion system
Standard trabeculectomy surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* One of the following diagnoses:
* primary open angle glaucoma
* chronic angle closure glaucoma
* pseudo exfoliation glaucoma
* pigment dispersion glaucoma
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Glaucoma Research & Education Group
OTHER
Queen's University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Robert Campbell
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert J Campbell, MD
Role: PRINCIPAL_INVESTIGATOR
Queen's University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hotel Dieu Hospital, Queen's University
Kingston, Ontario, Canada
Toronto Western Hospital, University of Toronto
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RC-2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.